10 November 2023

Enteric coated risedronate 35mg for osteoporosis

Clinical Rheumatology

Profressor Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis.

To read the rest of this article you need to be a Medical Republic Member and registered with AHPRA, Please login below if you have an account or sign up to join.

Join Now / Login